These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38992013)

  • 1. SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023.
    Carreño JM; Wagner AL; Monahan B; Singh G; Floda D; Gonzalez-Reiche AS; Tcheou J; Raskin A; Bielak D; Morris S; Fried M; Yellin T; Sullivan L; ; Sordillo EM; Gordon A; van Bakel H; Simon V; Krammer F
    Nat Commun; 2024 Jul; 15(1):5847. PubMed ID: 38992013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City.
    Stadlbauer D; Tan J; Jiang K; Hernandez MM; Fabre S; Amanat F; Teo C; Arunkumar GA; McMahon M; Capuano C; Twyman K; Jhang J; Nowak MD; Simon V; Sordillo EM; van Bakel H; Krammer F
    Nature; 2021 Feb; 590(7844):146-150. PubMed ID: 33142304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening".
    Jin DK; Nesbitt DJ; Yang J; Chen H; Horowitz J; Jones M; Vandergaast R; Carey T; Reiter S; Russell SJ; Kyratsous C; Hooper A; Hamilton J; Ferreira M; Deng S; Straus D; Baras A; Hillyer CD; Luchsinger LL
    PLoS One; 2021; 16(4):e0250319. PubMed ID: 33909646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France.
    Woudenberg T; Pelleau S; Anna F; Attia M; Donnadieu F; Gravet A; Lohmann C; Seraphin H; Guiheneuf R; Delamare C; Stefic K; Marlet J; Brochot E; Castelain S; Augereau O; Sibilia J; Dubos F; Meddour D; Guen CG; Coste-Burel M; Imbert-Marcille BM; Chauvire-Drouard A; Schweitzer C; Gatin A; Lomazzi S; Joulié A; Haas H; Cantais A; Bertholon F; Chinazzo-Vigouroux MF; Abdallah MS; Arowas L; Charneau P; Hoen B; Demeret C; Werf SV; Fontanet A; White M
    EBioMedicine; 2021 Aug; 70():103495. PubMed ID: 34304047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023.
    Kinoshita R; Miyamoto S; Sakuraba S; Sugihara J; Suzuki M; Suzuki T; Yoneoka D
    Emerg Infect Dis; 2024 Jun; 30(6):1267-1270. PubMed ID: 38782366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system.
    Chervo TC; Elkin EP; Nugent JR; Valice E; Amsden LB; Ergas IJ; Munneke JR; Flores M; Saelee GN; Hsiao CA; Schapiro JM; Quesenberry CP; Corley DA; Habel LA; Kushi LH; Skarbinski J
    PLoS One; 2024; 19(6):e0303303. PubMed ID: 38900738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age dependent discrepancy between SARS-CoV-2 anti-nucleoprotein antibody and anti-RBD spike protein antibody in children reflects vaccine coverage.
    Fujii Y; Ishigaki H; Miyairi I; Niizeki N; Nagura O; Yamashita K; Maekawa M; Furuhashi K
    J Infect Chemother; 2024 Jul; 30(7):646-650. PubMed ID: 38309499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings From New York City, 13 May to 21 July 2020.
    Pathela P; Crawley A; Weiss D; Maldin B; Cornell J; Purdin J; Schumacher PK; Marovich S; Li J; Daskalakis D;
    J Infect Dis; 2021 Jul; 224(2):196-206. PubMed ID: 33836067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of SARS-CoV-2 Antibodies in New York City Adults, June-October 2020: A Population-Based Survey.
    Parrott JC; Maleki AN; Vassor VE; Osahan S; Hsin Y; Sanderson M; Fernandez S; Levanon Seligson A; Hughes S; Wu J; DeVito AK; LaVoie SP; Rakeman JL; Gould LH; Alroy KA
    J Infect Dis; 2021 Jul; 224(2):188-195. PubMed ID: 34086923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence and levels of IgG antibodies after COVID-19 infection or vaccination.
    Soeorg H; Jõgi P; Naaber P; Ottas A; Toompere K; Lutsar I
    Infect Dis (Lond); 2022 Jan; 54(1):63-71. PubMed ID: 34520315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Immunity and Covid-19 Severity with Omicron Variant in South Africa.
    Madhi SA; Kwatra G; Myers JE; Jassat W; Dhar N; Mukendi CK; Nana AJ; Blumberg L; Welch R; Ngorima-Mabhena N; Mutevedzi PC
    N Engl J Med; 2022 Apr; 386(14):1314-1326. PubMed ID: 35196424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 seroprevalence in the city of Puerto Madryn: Underdiagnosis and relevance of children in the pandemic.
    Schonfeld D; Fernández H; Ramírez J; Acosta D; Becerra J; Wettstein M; Strella T; Vaccaro M; Arias S; Rodríguez Calvo V; Neme R; Pérez-Chada D
    PLoS One; 2022; 17(3):e0263679. PubMed ID: 35286328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
    He Z; Ren L; Yang J; Guo L; Feng L; Ma C; Wang X; Leng Z; Tong X; Zhou W; Wang G; Zhang T; Guo Y; Wu C; Wang Q; Liu M; Wang C; Jia M; Hu X; Wang Y; Zhang X; Hu R; Zhong J; Yang J; Dai J; Chen L; Zhou X; Wang J; Yang W; Wang C
    Lancet; 2021 Mar; 397(10279):1075-1084. PubMed ID: 33743869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A longitudinal study on SARS-CoV-2 seroconversion, reinfection and neutralisation spanning several variant waves and vaccination campaigns, Heinsberg, Germany, April 2020 to November 2022.
    Schulte B; Richter E; Büning A; Baum M; Breuer A; Zorn J; König J; Geiger M; Eschbach-Bludau M; Heuser J; Zölzer D; Korencak M; Hollstein R; Beins E; Emmert D; Aldabbagh S; Eis-Hübinger AM; Streeck H
    Euro Surveill; 2024 Jun; 29(26):. PubMed ID: 38940003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 cellular and humoral responses in vaccine-naive individuals during the first two waves of COVID-19 infections in the southern region of The Netherlands: a cross-sectional population-based study.
    Hanssen DAT; Arts K; Nix WHV; Sweelssen NNB; Welbers TTJ; de Theije C; Wieten L; Pagen DME; Brinkhues S; Penders J; Dukers-Muijrers NHTM; Hoebe CJPA; Savelkoul PHM; van Loo IHM
    Microbiol Spectr; 2024 Jun; 12(6):e0012624. PubMed ID: 38686954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden.
    Castro Dopico X; Muschiol S; Christian M; Hanke L; Sheward DJ; Grinberg NF; Rorbach J; Bogdanovic G; Mcinerney GM; Allander T; Wallace C; Murrell B; Albert J; Karlsson Hedestam GB
    J Intern Med; 2021 Sep; 290(3):666-676. PubMed ID: 34008203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020.
    George JA; Khoza S; Mayne E; Dlamini S; Kone N; Jassat W; Chetty K; Centner CM; Pillay T; Maphayi M; Mabuza D; Maposa I; Cassim N
    S Afr Med J; 2021 Nov; 111(11):1078-1083. PubMed ID: 34949273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.